Back to Journals » Drug Design, Development and Therapy » Volume 9

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Total article views   HTML views PDF downloads Totals
22,707 Dovepress* 17,658+ 2,256 19,914
PubMed Central* 5,049 1,599 6,648
Totals 22,707 3,855 26,562
*Since 7 January 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar